Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Precigen, Inc. logo

Precigen, Inc. (PGEN) Stock Ticker

NASDAQ: PGEN · Healthcare · Biotechnology
$7.75+0.65%
USD · as of 2026-09-28 · market cap $2.8B
Open PGEN in TickrDownload for iPhone

PGEN right now

27% of the float is sold short.
bullishBreaking out: New 52-week high with a golden cross
Tickr signals on PGEN
Breaking outNew 52-week high with a golden cross
Options expect by Oct 6±10.4%
Options expect by Oct 29±21.4%
Priced in for Nov 12 earnings±26.0%
IV rank (30-day)21% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full PGEN picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on PGEN
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Precigen, Inc.

Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore, Precigen utilizes its AdenoVerse platform, a library of engineered adenovectors for gene delivery and immunotherapy applications, alongside L. lactis, a food-grade bacterium. The company also provides RheoSwitch, an inducible gene switch system offering quantitative, dose-proportionate control over target protein expression's timing and amount; kill switches, designed to selectively eliminate cell therapies within the body; tissue-specific promoters for targeted gene expression; the UltraCAR-T platform for cancer treatment; and the ActoBiotics platform, which employs genetically modified bacteria to deliver proteins and peptides directly to mucosal sites. Precigen maintains strategic collaboration and license agreements with Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., and Intrexon Energy Partners I and II, LLC. Established in 1998, Precigen, Inc., previously known as Intrexon Corporation, adopted its current name in January 2020 and is headquartered in Germantown, Maryland.

PGEN stock facts

Ticker symbolPGEN
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$2.8B
CEOHelen Sabzevari
Employees160
HeadquartersGermantown, MD, US
IPO date2013-08-08
Websitewww.precigen.com

What you can see for PGEN on Tickr

Live PGEN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PGEN report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Precigen, Inc.?

The ticker symbol for Precigen, Inc. is PGEN, listed on the NASDAQ Global Select.

What is PGEN?

Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA…

HomeExploreMarketLists
All pages